BMY Swing Trade
Bristol-Myers Squibb Co (BMY)
BMY has been on a downtrend since December 2022 but since its recent Dividend payout followed by good earnings, it seems like a reversal of trend is in the making.
Following a month-long consolidation period, a bullish candlestick formation at today's close could indicate a favourable entry point. I anticipate a short-term price movement towards $53.
BMY has been on a downtrend since December 2022 but since its recent Dividend payout followed by good earnings, it seems like a reversal of trend is in the making.
Following a month-long consolidation period, a bullish candlestick formation at today's close could indicate a favourable entry point. I anticipate a short-term price movement towards $53.
Trade closed: target reached
TP reached!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.